RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB)
Abroad (travel likely)RecruitingPHASE1
Conditions
Recurrent Medulloblastoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
UF Health Shands Children's Hospital, Gainesville, Florida, United States
Contact: Principal Investigator (John Ligon, MD)
Study leads
Sabine Mueller, MD, PhD
Study Chair
University of California, San Francisco
Elias Sayour, MD, PhD
Principal Investigator
University of Florida